autologus CD34+ cells transfected with retroviral vector containing adenosine deaminase gene

autologus CD34+ cells transfected with retroviral vector containing adenosine deaminase gene
Trade Name
Orphan Indication Severe combined immunodeficiency
USA Market Approval USA
USA Designation Date 2009-08-26 00:00:00
Sponsor Glaxo Group Limited;I-3 Iron Bridge Road, Stockley Park West;